A recent research study led by Karin Schelch and Michael Grusch from MedUni Vienna identified the oncoprotein YB-1 as an attractive therapeutic target in PM and demonstrates that indirect targeting of YB-1 is a promising approach to enhance sensitivity to chemo- and radiotherapy.
BiotechReality – News | Reports | Notes | Science
Explore the frontiers of Biotechnology, Pharma industry and Science with BiotechReality.com. We publish news, reports, and articles. We are exclusively publishing fellowship and studentship updates to light up the way for graduates to find a suitable research position in academia or industry.
JobFinder
Subscribe to Newsletter
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary.